Article

A Tumor Suppressor-Regulated Cell Cycle Derived Gene Signature is Prognostic of Recurrence Risk in Prostate Cancer

2018-08-21

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> The clinical behavior of prostate cancer (PCa) is variable, and while the majority of cases remain indolent, 10% of patients progress to deadly forms of the disease. Current clinical predictors used at the time of diagnosis have limitations to accurately establish progression risk. Here we describe the development of a tumor suppressor regulated, cell-cycle gene expression b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2aec3a1c-bf90-500a-969a-d69f95ed4ed6
DOI: 10.1101/397331

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Tumor Suppressor-Regulated Cell Cycle Derived Gene Signature is Prognostic of Recurrence Risk in Prostate CancerDOI 10.1101/397331Read

Gene expression profiling predicts clinical outcome of prostate cancerSemantic proximity Read

Comprehensive Analysis of Cell Cycle-Related Genes in Patients With Prostate CancerSemantic proximity Read

Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomySemantic proximity Read

Key Genes And Pathways Controlled By E2F1 In Human Castration-Resistant Prostate Cancer CellsSemantic proximity Read

Global Transcriptome Analysis of Formalin-Fixed Prostate Cancer Specimens Identifies Biomarkers of Disease RecurrenceSemantic proximity Read

Machine Learning-Based Identification of Co-expressed Genes in Prostate Cancer and CRPC and Construction of Prognostic ModelsSemantic proximity Read

5 Gleason score-associated gene signatures serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate AdenocarcinomaSemantic proximity Read

Machine learning-based identification of co-expressed genes in prostate cancer and CRPC and construction of prognostic modelsSemantic proximity Read

Unveiling the NEFH+ malignant cell subtype: Insights from single-cell RNA sequencing in prostate cancer progression and tumor microenvironment interactionsSemantic proximity Read

Biomarker-based outcome prediction in prostate adenocarcinoma depends on the <i>TMPRSS2-ERG</i> statusSemantic proximity Read

Integrative CRISPR-Cas9 Screening Reveals Lethal Genes Driving Metastasis and Prognosis in Prostate AdenocarcinomaSemantic proximity Read

TOP2A and PPARGC1A differentiate chromatin regulator-related subtypes for prostate cancer patients undergoing radical prostatectomySemantic proximity Read